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Introduction
The ER consists of a series of sheets and dynamic tubules. The 
tubules make functionally important contacts with other or-
ganelles, including endosomes, mitochondria, and the plasma 
membrane (Raiborg et al., 2015). Contacts with endosomes are 
extensive, dynamic, and typically associated with microtubules 
(Friedman et al., 2013). They have been implicated in important 
cellular functions, including in fission of tubules from the en-
dosomal body (Rowland et al., 2014). Endosomal tubules orig-
inate from early and late endosomes and sort receptors, such 
as the transferrin (TfnR) and mannose 6-phosphate (M6PR) 
receptors, for recycling away from the degradative lysosomal 
pathway (Maxfield and McGraw, 2004). The molecular ma-
chinery underlying the establishment and breakage of these 
fission- related ER–endosome contact sites is not completely 
understood, although the ER protein VAP has been implicated, 
via a mechanism that involves regulating endosomal phospha-
tidylinositol 4-phosphate levels and thereby the function of the 
WASH complex, an actin nucleating machinery that promotes 
endosomal tubule fission (Dong et al., 2016).
Previously, we proposed that efficient endosomal tubule 
fission requires the microtubule-severing ATPase spastin, as 
cells lacking spastin had increased endosomal tubulation cou-
pled with defective TfnR recycling (Allison et al., 2013). How-
ever, it is not known whether spastin promotes ER-associated 
endosomal tubule fission or a distinct fission reaction not in-
volving the ER. Rescue of the endosomal tubulation phenotype 
required spastin’s microtubule-severing ATPase capacity and 
its ability to bind the endosomal proteins IST1 and CHMP1B, 
components of the endosomal sorting complex required for 
transport (ESC RT)-III machinery (Allison et al., 2013). Be-
cause we also observed increased endosomal tubulation in cells 
lacking IST1, we suggested that IST1 is a key endosomal pro-
tein coordinating spastin’s role in tubule fission (Allison et al., 
2013). Consistent with this, IST1 and CHMP1B have been pro-
posed to form a helical complex involved in scission of tubular 
membranes (McCullough et al., 2015).
Autosomal dominant mutations in the gene encoding 
spastin (SPA ST/SPG4) cause hereditary spastic paraplegia 
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(HSP), a disease characterized by axonal degeneration in the 
central motor tracts. They are the single most common cause of 
the disease, being found in ∼40% of autosomal dominant HSP 
families (Blackstone et al., 2011). Study of HSPs has informed 
the molecular pathology of axonopathy, a process contributing 
to common neurological disorders, including Alzheimer de-
mentia and multiple sclerosis. Of >70 known genes mutated in 
HSP (Hensiek et al., 2015), most encode proteins functioning 
in membrane traffic/modeling, with subsets of these involved 
in ER shaping (including those associated with the most com-
mon forms of HSP: spastin, atlastin-1, and REEP1), endoso-
mal tubule fission (including the WASH complex member 
strumpellin as well as spastin), and lysosomal biogenesis and 
function (including SPG11, SPG15, and AP5 complex mem-
bers) (Harbour et al., 2010; Park et al., 2010; Blackstone et al., 
2011; Montenegro et al., 2012; Allison et al., 2013; Chang et 
al., 2014; Renvoisé et al., 2014; Hirst et al., 2015; Raza et al., 
2015; Varga et al., 2015). No mechanism linking these subsets 
into a unifying disease pathway is known, although spastin has 
been implicated in two of these processes, hinting that there 
may be some connection.
Here we investigate the role of spastin in endosomal tu-
bule fission and examine consequences of failure of this process. 
We show that endosomal IST1 and an ER-localized isoform of 
spastin (M1-spastin) interact at ER–endosome contacts to pro-
mote endosomal tubule fission. When this fails because of lack 
or abnormality of spastin, defects in M6PR sorting cause defec-
tive lysosomal enzyme traffic accompanied by abnormal lyso-
somal morphology, including in primary cortical neurons from 
a spastin-HSP mouse model, patient fibroblasts, and induced 
pluripotent stem cell (iPSC)-derived patient neurons. Consis-
tent with a critical role for ER-mediated endosomal tubule fis-
sion in controlling lysosome function, we observed strikingly 
similar lysosomal abnormalities in cells lacking another HSP 
protein, the WASH component strumpellin, and in mouse neu-
rons lacking the ER-shaping HSP protein REEP1. Thus as well 
as characterizing molecular machinery that drives ER-mediated 
endosomal tubule fission and linking a disease process to ER–
endosome contact machinery, by coupling ER-mediated endo-
somal tubule fission to lysosome function, we have uncovered 
a unifying pathway that links several groups of HSP proteins 
previously considered distinct and includes the most com-
mon subtypes of HSP. We propose that this is a central path-
way of HSP pathogenesis.
Results
Spastin promotes endosomal tubule fission
Our previous observations suggested that spastin promotes 
endosomal tubule fission, but we had not proven this directly 
(Allison et al., 2013). To address this, we performed live-cell 
microscopy in human fibroblasts (MRC5 cells, whose flat mor-
phology is amenable to live-cell imaging) stably expressing the 
endosomal tubular marker GFP-SNX1 (Fig.  1  A, Fig. S1 A, 
and Video 1). In cells depleted of spastin by siRNA transfec-
tion, mean GFP-SNX1 tubule duration was increased (Fig. 1 A, 
bottom left; and Fig. S1 B). We classified the fates of individ-
ual tubules into three categories; fission near the tubule base 
(within 1.5 µm of endosomal body), fission elsewhere on the 
tubule, and collapse into the endosomal body without breakage 
(likely representing failure of fission). In cells lacking spastin, 
the proportion of tubules that broke at the base was reduced, 
whereas the proportion that collapsed or broke elsewhere on the 
tubule was increased (Fig. 1 A, bottom middle). The duration 
of tubules undergoing these distinct fates was longer in cells 
lacking spastin (Fig. 1 A, bottom right). Consistent with these 
findings, in fixed MRC5 cells lacking spastin, a significantly 
increased percentage of cells had endogenous SNX1 tubules 
>2 µm long (Fig. S1 C).
We examined the physiological relevance of these findings 
using murine embryonic fibroblasts (MEFs) from a knock-in 
mouse model expressing, at physiological levels, spastin in-
corporating the N384K mutation (equivalent to human disease 
mutation N386K), rendering the protein ATPase defective and 
so unable to sever microtubules. The mice develop a gait and 
axonal phenotype consistent with HSP (Connell et al., 2016). In 
fixed spastinN384K/N384K MEFs, we saw an increased percentage 
of cells with endogenous SNX1 tubules >2 µm long (Fig. S1 
D). Live-cell experiments using GFP-SNX1 stably expressed at 
subendogenous levels demonstrated increased tubule duration 
in spastinN384K/N384K MEFs, with fewer tubules breaking near 
the endosomal body, more breaking at other points along the 
tubule, and a trend toward increased tubule collapse (Video 2; 
and Fig. S1, A and E). We concluded that spastin is required 
for efficient endosomal tubule fission, and this function re-
quires its ATPase activity.
Spastin regulates ER-associated endosomal 
tubule fission
Endosomal tubule fission has been reported to occur at sites of 
ER contact in ∼80% of cases (Rowland et al., 2014). However, 
the specific relationship between SNX1 tubule fission and the 
ER, and the role of spastin in this process, has not been deter-
mined. We imaged living MRC5 cells stably expressing GFP-
SNX1 at near-endogenous levels (Fig. S1 A) and transiently 
expressing the ER marker RFP-KDEL. In both wild-type and 
spastin-depleted cells, >80% of endosomal tubules that arose 
in an area of resolvable ER broke at a point where they crossed 
an ER tubule (Fig. 1, B and C; and Video 3). The duration of 
apparent contact between ER and endosomal tubules from es-
tablishment until fission or collapse was longer in cells lacking 
spastin (Fig. 1 D). EM demonstrated a significant increase in 
the number of ER contacts (apposing membranes within 20 nm) 
with early and late endosomes in spastinN384K/N384K MEFs 
and HeLa cells depleted of spastin (Figs. 1 E and S1 F), con-
sistent with the idea that ER–endosome contacts are broken by 
spastin- mediated endosomal tubule fission. Considered together, 
our observations indicate that spastin drives ER- associated 
endosomal tubule fission.
IST1–spastin interaction links 
endosomes to the ER
Spastin has two main isoforms, M1-spastin and M87-spastin 
(Fig. S2 A; Claudiani et al., 2005). M1-spastin localizes to the 
ER at steady state, where it interacts, via a hydrophobic region 
not present in M87-spastin, with ER-shaping proteins of the 
REEP, reticulon, and atlastin families, including several impli-
cated in HSP (Sanderson et al., 2006; Connell et al., 2009; Park 
et al., 2010; Montenegro et al., 2012). In contrast, M87-spastin 
is predominantly cytosolic but dynamically recruited to endo-
somes by interactions with the ESC RT-III proteins, notably 
CHMP1B and IST1 (Reid et al., 2005; Agromayor et al., 2009; 
Connell et al., 2009; Renvoisé et al., 2010). We showed pre-
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Figure 1. Spastin promotes endosomal tubule fission at ER tubules. (A) Stills from Video 1 of MRC5 cells stably expressing GFP-SNX1, showing tubule 
fission in control cell or cell depleted of spastin by siRNA knockdown (KD). The main panels show an overview of the cell; the small panels illustrate a single 
fission event. Yellow arrowheads track the tip of the elongating endosomal tubule and the fissioned domain. Time 0 corresponds to the frame in which the 
tubules first emerge. Corresponding histograms show mean tubule duration (left), mean percentage of tubules with different fates (middle), and duration 
of tubules with each fate (right). left, n = 6 experiments; middle and right, n = 5; see Materials and methods for numbers of tubules analyzed in these and 
subsequent live cell experiments. Bars in small panels, 2 µm. (B) Stills from Video 3 of MRC5 cells stably expressing GFP-SNX1 and transiently expressing 
RFP-KDEL, showing mock-transfected (top) or spastin KD (bottom) cell. The main panels show an overview of the cell; the small panels illustrate a single 
fission event. White arrowhead marks approximate site of fission. Time 0 corresponds to the frame in which the tubules first emerge. Bars in small panels, 
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viously that M87-spastin rescues the endosomal tubule fission 
defect in cells lacking endogenous spastin. Surprisingly, in view 
of its ER localization, small amounts of M1-spastin were also 
sufficient to rescue the endosomal tubule fission defect (Allison 
et al., 2013). The discovery of ER-associated endosomal tubule 
fission provides a possible explanation for this: M1-spastin func-
tions at ER contact sites involved in endosomal tubule fission.
Because we had already determined that IST1 is a key 
endosomal protein coordinating spastin’s role in endosomal tu-
bulation in HeLa cells (Allison et al., 2013), we began by ex-
amining whether IST1–M1-spastin interaction defined a set of 
ER–endosome contact sites involved in endosomal tubule fission. 
We first formally verified that the increased endosomal tubulation 
observed in cells lacking IST1 represented defective tubule fis-
sion, quantifying the fate and duration of GFP-SNX1 endosomal 
tubules in MRC5 cells. We found results similar to those for spas-
tin, with an increased tubule duration and decreased breakage 
near the tubule base in cells lacking IST1 (Video 4 and Fig. S2 B).
IST1 has been reported to localize to an endosomal sub-
domain juxtaposed to SNX1 (Agromayor et al., 2009), and con-
sistent with this, we saw colocalization of IST1 with endosomal 
markers and close proximity to SNX1 signal in HeLa or MRC5 
cells (Fig. S2 C). Furthermore, in HeLa cells, we observed punc-
tate colocalization between endogenous spastin and IST1 and 
between stably expressed Myc-M1-spastin and IST1 (Fig. 2 A). 
Consistent with the idea that spastin and IST1 function to pro-
mote endosomal tubule fission, using superresolution Airyscan 
microscopy in MRC5 cells, we detected colocalization between 
stably expressed GFP-M1-spastin and endogenous IST1 on en-
dosomal tubules labeled by mCherry-SNX1 (Fig. 2 B). This co-
localization was often, but not always, located close to the base 
of the SNX1 tubule and was observed at points of tubule con-
striction (Fig. 2 B, Fig. S2 D, and Video 5). In the context of the 
well-validated IST1–spastin interaction, we concluded that the 
ER-localized M1-spastin isoform interacts with endosomal IST1 
on SNX1 tubules (Agromayor et al., 2009; Renvoisé et al., 2010).
We next examined what happens to endosomal tubule 
fission when IST1–spastin binding is disrupted. Spastin’s MIT 
domain interacts with MIT-interacting motifs (MIMs) in the C 
terminus of IST1 (Agromayor et al., 2009; Renvoisé et al., 2010). 
Consistent with our previous demonstration that spastin’s regula-
tion of endosomal tubule fission requires an MIT domain capa-
ble of interacting with ESC RT-III (Allison et al., 2013), siRNA 
rescue experiments showed that only IST1 containing the MIMs 
could rescue the increased endosomal tubulation seen in cells 
lacking endogenous IST1 (Figs. 2 C and S2 E). Considered to-
gether, our experiments indicate that IST1 and M1-spastin in-
teract at ER–endosome contact sites, and that this interaction is 
required for efficient ER-mediated fission of endosomal tubules.
Spastin and IST1 promote endosome-to-
Golgi traffic
M6PRs capture M6P-tagged lysosomal enzymes at the TGN 
and traffic them to endosomes. After cargo release, M6PRs 
are retrieved back to the TGN, via interaction with the retromer 
complex, in SNX1/SNX2-positive endosomal tubules (Carlton et 
al., 2004; Seaman, 2012). To understand whether spastin-driven 
endosomal tubule fission is required for this retrieval, we used a 
HeLa line stably expressing a reporter protein comprising CD8 
fused to the cytoplasmic tail of the cation-independent M6PR 
(ciM6PR; Seaman, 2007). As some CD8-M6PR fusion pro-
tein is present at the plasma membrane and subject to endo-
cytosis and subsequent trafficking, anti-CD8 antibody uptake 
experiments reveal the dynamics of endosome to TGN M6PR 
traffic. In wild-type cells, we found strong colocalization be-
tween the Golgi marker GOL PH3 and CD8-M6PR 30 min after 
uptake (Fig. 3 A). In cells lacking spastin, colocalization between 
GOL PH3 and CD8-M6PR was reduced (Fig. 3 A), indicating that 
spastin is required for efficient endosome-to-Golgi traffic of 
M6PRs. Cells lacking IST1 showed a similar trend (Fig. 3 A).
Failure to sort M6PRs away from endosomes may result 
in increased colocalization of M6PR with lysosomal markers. 
In HeLa cells lacking spastin, colocalization between ciM6PR 
and the lysosomal marker LAMP1 was significantly increased 
(Figs. 3 B and S3 A). This phenotype was rescued by both wild-
type M1-spastin and M87-spastin (Fig. 3 B and Fig. S3, A and 
B). However, forms of spastin engineered to block interaction 
with ESC RT-III (by F124D mutation) or microtubules (by dele-
tion of the MTB), or made unable to hydrolyze ATP and sever 
microtubules (by K388R mutation), gave minimal or no rescue 
(Fig. 3 C and Fig. S3, C and D; Evans et al., 2005; White et 
al., 2007; Yang et al., 2008). These results are consistent with 
the properties of spastin that promote endosomal tubule fission 
(Allison et al., 2013).
Spastin controls lysosomal morphology
Defective endosome-to-Golgi M6PR traffic typically reduces 
availability of M6PRs at the TGN, resulting in reduced capture 
and traffic to endosomes of M6P-tagged lysosomal enzymes, 
which are instead secreted. Consistent with this, secretion of 
the lysosomal enzyme cathepsin D was increased in cells lack-
ing spastin or IST1 (Figs. 4 A and S4 A). We predicted that 
this abnormal enzyme sorting would cause a lysosomal defect. 
In HeLa cells lacking spastin or IST1, and in spastinN384K/N384K 
MEFs, we saw an increase in the proportion of cells with large 
LAMP1-positive lysosomes (Figs. 4 B and S4 B).
We characterized the lysosomal phenotype in cells lack-
ing spastin in more detail. We quantified the overall size dis-
tribution of lysosomes in HeLa cells, visualizing the terminal 
degradative compartment by imaging fluorescent puncta 20 h 
after a 4-h incubation with fluorescent dextran. The mean sur-
face area of individual lysosomes was significantly greater in 
spastin-depleted cells (Fig. S4 C; mean ± SEM: mock, 0.78 ± 
0.018 µm2; spastin-depleted, 0.88 ± 0.023 µm2). However, this 
difference was predominantly caused by an increased number 
of very large lysosomes in spastin-depleted cells; when lyso-
somes with a surface area >2.5 µm2 (equivalent to a diameter of 
1.8 µm, assuming a circular shape) were excluded, there was no 
1 μm. The corresponding histograms show percentage of fission events occurring at site of ER tubule overlap (C) and the duration of overlap between 
ER and endosomal tubule before breakage or collapse (D); n = 3 experiments. (E) EM of early endosome (EE) and multivesicular body (MVB) structures 
in MEFs from spastinwt/wt (WT), spastinwt/N384K (HET), and spastinN384K/N384K (KI) animals. Arrows indicate points of ER contact, and the mean number of 
contacts is quantified (pooled, EE and MVB results combined). n = 3 experimental repeats. See Materials and methods for number of structures analyzed. 
Bars: (light micrographs, large panels) 10 µm; (EM) 500 nm. All histograms show mean ± SEM. P-values generated by two-tailed Student’s t test (A, C, 
and D) or ANO VA for effect of genotype (E).
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significant difference between wild-type and spastin-depleted 
cells (mock, 0.73 ± 0.015 µm2; spastin-depleted, 0.76 ± 0.017 
µm2). Cells lacking spastin also had a moderate but significant 
reduction in the number of lysosomes per cell (Fig. S4 D), but 
there was no significant difference in the percentage of lyso-
somes that were located in the center of the cell versus the pe-
riphery (defined as within 5 µm of the cell edge; Fig. S4 E). We 
determined whether spastin depletion affected lysosomal pH by 
a quantitative ratiometric fluorescent microscopic method in-
volving uptake into the terminal lysosomal compartment of sep-
arate pH-quenchable and pH-insensitive fluorescently labeled 
dextrans (Bright et al., 2016; Johnson et al., 2016). HeLa cells 
lacking spastin had a strikingly reduced lysosomal pH, with a 
mean pH of 4.3, versus pH 5.2 in wild-type cells (Fig. 4 C), un-
derscoring functional differences caused by spastin depletion.
We examined lysosomal ultrastructure. In HeLa cells 
lacking spastin or IST1, and in spastinN384K/N384K MEFs, we 
found highly abnormal endolysosomes and lysosomes that had 
a spectrum of abnormal appearances, including enlarged organ-
elles with internal membrane that was tightly or more loosely 
packed into linear or circular stacks or coils, organelles with a 
dense network or honeycomb appearance, and more vacuolar 
structures, which contained only a few intraluminal vesicles or 
membranes. Organelles with intermediate appearances were ob-
Figure 2. Spastin–IST1 interaction drives endosomal tubule fission. (A) Wild-type HeLa cells or HeLa cells stably expressing Myc-M1-spastin were imaged 
by confocal immunofluorescence microscopy (IF) with the antibodies indicated. Arrowheads indicate colocalized puncta. In cells labeled with endoge-
nous spastin, soluble cytosolic signal was removed using a prefixation cytosol extraction buffer. (B) MRC5 cells stably expressing GFP-M1 spastin and 
mCherry-SNX1 were labeled with IST1 and GFP antibodies and imaged with Airyscan IF. Small panels show individual channels. Arrowheads indicate a 
region of colocalization between IST1 and spastin at the base of a SNX1 tubule. (C) Wild-type HeLa cells or cells expressing the siRNA-resistant proteins 
indicated (see schematic) were subjected to endogenous IST1 KD, then fixed and visualized by IF for endogenous SNX1. Mean ± SEM number per cell of 
SNX1 tubules >2 µm long is shown in the histogram (n = 5). Bars: (A and C, main image) 10 µm; (A and C, magnified insets) 5 µm; (B) 500 nm. P-values 
generated by two-tailed Student’s t test.
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Figure 3. Spastin and IST1 regulate endosome-to-Golgi traffic. (A) Anti-CD8 antibody uptake experiments in HeLa cells stably expressing CD8-ciM6PR 
and GFP-GOL PH3 (a Golgi marker), and subjected to IST1 or spastin KD. Cells were fixed at the times indicated, and CD8 and GFP signal were visualized 
by confocal immunofluorescence microscopy. Mean ± SEM colocalization between the markers (Pearson’s correlation) at 30 min is shown in the histogram 
(n = 6). Bars, 10 µm. (B and C) Wild-type HeLa cells or HeLa cells stably expressing the siRNA-resistant spastin proteins indicated were subjected to endogenous 
spastin KD, fixed, and visualized for M6PR and LAMP1. Mean ± SEM colocalization was plotted. n = 4 (B) or 5 (C). In B and C, p-values between the HeLa mock 
and all other mock conditions were not significant. P-values generated by two-tailed Student’s t test.
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Figure 4. Spastin and IST1 regulate lysosomal enzyme traffic and lysosome morphology. (A) HeLa cells were subjected to spastin or IST1 KD, then protein 
precipitated from collected culture medium was immunoblotted for pro–cathepsin D (Pro-CatD). Coomassie staining validates equal loading. Blots were 
quantified, and the mean ± SEM fold-change in Pro-CatD secretion was plotted (n = 5). (B) HeLa cells were subjected to spastin KD, fixed, and labeled 
for LAMP1, then the diameter of the largest lysosome was measured in 100 cells/condition. The mean ± SEM percentage of cells with largest lysosome 
>1.8 µm and mean diameter of the largest lysosome are shown (n = 4). (C) HeLa cells were subjected to spastin KD and incubated in culture medium 
with dextran-Oregon Green (DexOG; fluorescence is acid quenched) or dextran-tetramethylrhodamine (DexRhod; fluorescence is pH insensitive) for a 4-h 
pulse, which was chased into the terminal degradative compartment for 20 h with dextran-free medium. Living cells were then imaged, and the ratio of 
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served, suggesting a continuous spectrum of abnormality. Ap-
proximately 50% of lysosomes had abnormal morphology on 
this spectrum (Figs. 4 D and S4 F). These abnormal lysosomes 
could be very large, but smaller organelles also frequently had 
abnormal morphology (Fig. S4 F). BSA-gold uptake confirmed 
that these abnormal structures had endosomal origin (Fig. 4 E).
We performed siRNA rescue experiments in HeLa cells 
to determine the properties of spastin required to regulate lyso-
somal size. M1-spastin or M87-spastin was sufficient to rescue 
lysosomal enlargement, and the rescue required the ability to 
hydrolyze ATP and bind ESC RT-III and microtubules (Fig. 4, 
F and G; and Fig. S5, A and B). Rescue experiments with IST1 
indicated that the spastin-binding MIMs were important for 
rescue of lysosomal size (Fig. S5 C). We concluded that sim-
ilar functional properties, including the ability to interact with 
IST1 and sever microtubules, are necessary for spastin to regu-
late both lysosomal morphology and endosomal tubule fission, 
consistent with the idea that defective endosomal tubule fission 
causes the lysosomal abnormality.
Lysosomal defects in spastin-HSP 
neuronal models
To explore the pathological relevance of our findings, we ex-
amined fixed primary cortical neurons, the cells that undergo 
axonopathy in HSP, and found an increased percentage of spas-
tinN384K/N384K neurons with large lysosomes versus wild-type 
cells (Fig. 5 A). In the cell body and neurites, lysosomes had 
abnormal ultrastructure, with many endolysosomal membrane 
coils and frequent gross enlargement (Fig.  5  B). Axons from 
spastinN384K/N384K mice develop swellings, and these were sig-
nificantly enriched for LAMP1-positive vesicles, compared 
with adjacent axonal segments of equivalent length (Fig. 5 C; 
Connell et al., 2016). Consistent with this, EM demonstrated 
that abnormal lysosomes often clustered in neurites (Fig. 5 B).
To test whether lysosomal abnormality was a feature in 
human patients, we examined fibroblast lines derived from three 
SPG4 (spastin)-HSP subjects (see Materials and methods for 
patient details) and found a significant increase in the propor-
tion of cells with large lysosomes (Fig. 6 A). These lysosomes 
had ultrastructural abnormalities highly reminiscent of those 
seen in the cell models described earlier (Fig.  6 B). We then 
differentiated human iPSCs reprogrammed from fibroblasts of 
SPG4-1 and Ctrl-2 into cortical neurons via neuronal precursor 
cell (NPC) cultures. We observed an increased percentage of 
neurons with enlarged lysosomes in cultures differentiated from 
two separate SPG4-1 NPC lines (Fig. 6 C). The axons of SPG4 
patient-derived neurons develop swellings (Denton et al., 2014; 
Havlicek et al., 2014), and these were enriched for lysosomes 
(Fig.  6  D). Ultrastructural studies on neurons differentiated 
from another iPSC line from the same patient demonstrated 
enlarged lysosomes containing abnormal membrane accumu-
lations (Fig.  6  E). Consistent with light microscopy findings, 
we observed clustered lysosomes containing accumulations of 
membrane in swollen sections of neurites (Fig. 6 E).
Lysosomal abnormalities in other 
HSP subtypes
Our results indicate that spastin indirectly controls lysosomal 
morphology by regulating ER-associated endosomal tubule 
fission. We examined whether other HSP proteins potentially 
implicated in this process also affected lysosomal morphology. 
Mutations in the SPG8/KIAA0196 gene encoding strumpel-
lin cause autosomal-dominant HSP (Valdmanis et al., 2007). 
The likely pathological mechanism is haplo-insufficiency, as 
the mutational spectrum includes a multiexon deletion and as 
no dominant-negative effects of mutant strumpellin have been 
identified in mammalian and zebrafish studies (Valdmanis et 
al., 2007; Freeman et al., 2013; Ishiura et al., 2014). Strum-
pellin participates in the WASH complex, which interacts with 
retromer and is required for efficient endosomal tubule fission. 
Consistent with this, cells depleted of strumpellin are known 
to have increased endosomal tubulation, including of SNX1 
tubules (Derivery et al., 2009; Gomez and Billadeau, 2009; 
Harbour et al., 2010). Furthermore, correct function of the 
WASH complex in nucleation of actin on endosomes is reg-
ulated by ER–endosome contacts involving the ER-localized 
VAP proteins (Dong et al., 2016). Against this background, we 
predicted that cells lacking strumpellin would develop a lyso-
somal phenotype. Indeed, we found that an increased proportion 
of HeLa cells lacking strumpellin had enlarged lysosomes. We 
saw this phenotype when strumpellin was depleted with four 
separate siRNA oligonucleotides, indicating that it is highly un-
likely to be caused by off-target siRNA effects (Fig. 7 A). The 
ultrastructure of endolysosomes in cells lacking strumpellin was 
strikingly similar to that observed in spastin-HSP models and 
ranged from organelles containing very tightly packed stacks 
or networks of membrane material to others in which the mem-
branes were more loosely coiled (Fig. 7 B). Again, we saw these 
ultrastructural abnormalities in cells depleted of strumpellin 
using four separate siRNA oligonucleotides (Fig. 7 B). Finally, 
in view of the defective endosomal tubule fission and increased 
endosomal tubulation in cells lacking strumpellin, we predicted 
that M6PR sorting away from the endolysosomal compartment 
would be reduced by strumpellin depletion. Consistent with 
this, we found increased colocalization between M6PR and 
LAMP1 in cells depleted of strumpellin (Fig. 7 C). Thus lack of 
strumpellin, another HSP protein that promotes endosomal tu-
bule fission, caused M6PR trafficking and lysosomal abnormal-
ities highly reminiscent of those seen in spastin-HSP models.
Alteration of ER morphology or dynamics by overexpres-
sion of an ER-shaping protein leads to defective ER-mediated 
endosomal fission (Rowland et al., 2014). We therefore pre-
dicted that abnormality of a classic ER-shaping HSP protein, 
REEP1, would cause a lysosomal phenotype. REEP1 interacts 
red to green pixels in 300 labeled puncta was measured and used to calculate pH, as described in Materials and methods. In the image, the differential 
interference contrast channel is shown to allow definition of the cell boundaries. The pH distribution of puncta from a single experiment is shown in the 
corresponding histograms. (D) Top, EM of HeLa cells subjected to spastin or IST1 KD, showing abnormal endolysosomal structures with abnormal dense 
membrane (arrowheads). Bottom, EM of MEFs from spastinN384K mice with genotypes indicated. Abnormal lysosomes indicated by arrowheads. (E) EM 
after BSA-gold uptake in mock-transfected or spastin-depleted HeLa cells. Right panels show the boxed areas indicated in the left panels; gold indicated by 
arrowheads. (F and G) Wild-type HeLa cells or HeLa cells stably expressing the siRNA-resistant spastin proteins indicated were subjected to endogenous 
spastin KD, fixed, and labeled for LAMP1. Mean ± SEM percentage of cells with largest lysosome >1.8 µm is plotted (n = 6, 100 cells/condition in each). 
All p-values generated by two-tailed Student’s t test, except C, in which differences in pH were analyzed using a two-tailed Mann–Whitney U test. Bars in 
light micrographs: (main image) 10 µm; (magnified insets) 5 µm. Bars in EM: 500 nm; (magnified images in E) 250 nm.
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with M1-spastin, and loss-of-function mutations in the encoding 
gene cause autosomal dominant HSP (Beetz et al., 2008; Park et 
al., 2010; Hu et al., 2011). We examined cortical neurons from a 
REEP1-HSP knockout (KO) mouse model that develops behav-
ioral and histological features compatible with HSP, and found 
an increase in the proportion of neurons with large lysosomes 
(Fig. 8 A; Beetz et al., 2013). The abnormal lysosomes had an 
ultrastructural appearance strikingly similar to those observed in 
spastin-HSP models, with the presence of stacked linear arrays of 
membranous material (Fig. 8 B). We concluded that lack of an ER- 
shaping HSP protein could also influence lysosomal morphology.
Discussion
CHMP1B and IST1 have been proposed to form a helical com-
plex on endosomal tubules, causing membrane constriction by 
promoting positive membrane curvature (McCullough et al., 
2015). Our results suggest a model in which recruitment of 
spastin to this complex, via IST1–MIM-spastin MIT interac-
tion, is critical for efficient breakage of endosomal tubules at 
ER-associated fission sites. Reconstructions of ER–endosome 
contacts demonstrate that they are frequently near microtubules 
(Friedman et al., 2013). As spastin’s ATPase activity, and hence 
Figure 5. Abnormal lysosomes in spastin-HSP mouse neurons. (A) Primary cortical neurons derived from spastinwt/wt (WT), spastinwt/N384K (HET), and 
spastinN384K/N384K (KI) animals were processed for immunofluorescence microscopy with the neuronal marker βIII-tubulin (red) and LAMP1 (green). The 
percentage of cells with largest lysosome >2 µm diameter was plotted for each animal (100 cells/animal). Bars indicate mean ± SEM. (B) EM of primary 
neuron cell bodies and neurites from animals with spastinN384K genotypes indicated. Boxed areas are in higher magnification on the right. (C) Confocal 
immunofluorescence microscopy (IF) of axonal swelling in spastinN384K/N384K mouse primary cortical neuron, labeled for LAMP1 and the axonal marker tau. 
Boxed areas shown in higher power in bottom panels. The mean ± SEM number of LAMP1-positive vesicles/µm of axonal length in 20 swellings versus 
adjacent axonal segments is plotted for three animals. Bars: (EM) 500 nm; (IF main panels) 10 µm; (IF magnified insets) 5 µm. P-values generated by two-
tailed Student’s t test.
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Figure 6. Lysosomal abnormalities in human spastin-HSP patients. (A) Skin fibroblasts from control subjects (top) or three spastin-HSP patients (SPG4; 
bottom) were fixed and visualized by confocal immunofluorescence microscopy (IF) for LAMP1. In each image, the inset panels show higher-magnification 
views of the boxed region. The diameter of the largest lysosome was measured in 100 fibroblast cells from each subject, and the mean percentage of 
cells with largest lysosome >2 µm was plotted in the corresponding histogram (n = 3 experimental repeats). Histogram shows mean ± SEM. (B) EM of 
fibroblasts from spastin-HSP patient and control (bottom, magnified views of boxed areas). (C) Cells from two human cortical neuron lines (SPG4-111 
and 112) and a control line (Ctrl-231) were fixed and labeled for βIII-tubulin (as a marker of neuronal differentiation) and LAMP1. The diameter of the 
largest lysosome was measured in βIII-tubulin–positive cells, and the mean ± SEM percentage of neurons with largest lysosome >2 µm was plotted in the 
corresponding histogram (n = 3/line, 100 cells/repeat). The two SPG4 neuronal lines were differentiated from separate NPC cultures derived from patient 
SPG4-1 iPSCs. (D) Cells from two human cortical neuron lines (SPG4-111 and 112) were labeled for βIII-tubulin and LAMP1. The images show a typical 
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ability to sever MTs, was required for endosomal tubule fission, 
our data best support the idea that severing of this subset of MTs 
is critical for the fission reaction (Fig. 9 A). We cannot fully 
exclude alternative models, e.g., where spastin drives fission by 
remodeling the CHMP1B-IST1 complex, analogous to VPS4’s 
role in remodeling ESC RT-III complexes (Henne et al., 2013).
This spastin-driven fission process is likely synergistic with 
the recently described function of VAP-A and -B, which act at 
ER–endosome contacts to regulate the WASH complex, thereby 
regulating fission of endosomal tubules (Dong et al., 2016). In-
deed, the observation that both spastin and VAP proteins interact 
with protrudin, another protein present at ER–endosome con-
tacts, suggests a mechanism by which these processes are coordi-
nated (Mannan et al., 2006; Raiborg et al., 2015).
Lack of both M1- and M87-spastin is required to inhibit 
endosomal tubule fission, as either rescued increased endoso-
mal tubulation in cells lacking endogenous spastin. M1-spastin 
is much less abundant than M87-spastin in all cells types. How-
ever, it is very efficient in promoting endosomal tubule fission: 
we obtained similar degrees of endosomal tubulation rescue 
with far lower concentrations of M1-spastin than M87-spas-
tin (Allison et al., 2013). We suggest that this is because M1- 
spastin, being at the ER, is ideally placed to interact with IST1 
at the base of the endosomal tubule where it contacts the ER. 
Spastin hexamerizes to sever microtubules, and because the two 
isoforms have the capacity to hetero-oligomerize, we propose 
that in the physiological situation, efficient hexamer formation 
involves nucleation by M1-spastin at the ER–endosome con-
tact, followed by rapid recruitment of M87-spastin from the 
abundant cytosolic pool (Fig. 9 A; Roll-Mecak and Vale, 2008). 
Furthermore, the redundancy of M1- and M87-spastin in rescu-
ing tubule fission provides an explanation for the observation 
that the vast majority of, if not all, spastin disease mutations 
affect both isoforms of the protein (Lumb et al., 2012).
Lysosomal abnormality, typically accompanied by lyso-
somal morphology remarkably similar to that observed in this 
study, has already been described in several rare HSP subtypes 
involving proteins that localize to endosomes, including SPG11, 
SPG15, and AP5 complex members (Khundadze et al., 2013; 
Renvoisé et al., 2014; Hirst et al., 2015; Varga et al., 2015). By 
showing that failure of ER-mediated endosomal tubule fission 
causes abnormal lysosomal morphology (Fig. 9, B and C), we 
now link HSP proteins that participate in this process to cor-
rect lysosomal function. As well as spastin and strumpellin, this 
potentially includes classic ER-shaping proteins, as correct ER 
morphogenesis also appears to be necessary for ER-mediated 
endosomal fission (Rowland et al., 2014). Consistent with this, 
we observed lysosomal abnormalities in cells lacking the arche-
typal ER-shaping protein REEP1. Because we found the lyso-
somal phenotype in cortical neurons from spastin and REEP1 
mouse models, and in the case of spastin, from patient fibroblasts 
and iPSC-derived neurons, it is very likely relevant to the patho-
genesis of HSP. Thus our work potentially links many classes 
of HSP protein previously considered functionally distinct, in a 
unifying pathway of HSP pathogenesis that incorporates all of 
the most common HSP subtypes, and which culminates in ly-
sosomal dysfunction (Fig. 9 D). This is consistent with the idea 
that lysosomal dysfunction contributes to axonopathy in prev-
alent neurological diseases (Ashrafi et al., 2014; Gowrishankar 
et al., 2015; Xie et al., 2015) and suggests that insights from 
HSP will inform our knowledge of these common disorders. 
A key challenge now is to understand how lysosomal abnor-
mality causes axonopathy. Lysosomal functions implicated in 
axonal disease, including autophagy or mitophagy, are strong 
pathological candidates (Ashrafi et al., 2014; Gowrishankar et 
al., 2015; Xie et al., 2015). Furthermore, lysosomal dysfunction 
may perturb lipid metabolism by inhibiting lysosomal degrada-
tion of membrane lipids or, by inhibiting receptor degradation, 
could disrupt key axonal signaling pathways such as bone mor-
phogenetic protein signaling, both of which have already been 
implicated in HSP (Blackstone et al., 2011; Tesson et al., 2015).
Materials and methods
Antibodies
Rabbit polyclonal anti-spastin (86–340) (raised against a glutathione 
S-transferase fusion protein that incorporated residues 86–340 of 
M1-spastin) and anti-SNX1 (raised against a glutathione S-transferase 
protein fused to mouse SNX1) antibodies were produced as previously 
described (Seaman, 2004; Connell et al., 2009). Monoclonal anti-CD8 
was produced by a mouse hybridoma cell line obtained from ATCC 
(CRL-8014), as described previously (Seaman, 2007). The SNX1 and 
CD8 antibodies were a gift of M. Seaman (University of Cambridge, 
Cambridge, England, UK). Mouse monoclonal anti-spastin (6C6) and 
α-tubulin (DM1A) and peroxidase-conjugated secondary antibodies for 
Western blotting were obtained from Sigma-Aldrich; mouse monoclo-
nal anti-myc (4A6) and rabbit polyclonal anti–Cathepsin D (219361) 
from EMD Millipore; mouse monoclonal anti-TfnR (13-6800) from 
Invitrogen; rabbit polyclonal anti-IST1 (51002-1-AP) from Proteintech 
Group; mouse monoclonal anti-SNX1 (611482), anti-EEA1 (610456), 
and anti-Rab5 (610724) from BD transduction laboratories; rabbit poly-
clonal anti-GFP (ab6556), anti–βIII-tubulin (ab18207), mouse mono-
clonal anti-M6PR (ab2733), and anti–Tau-5 (ab80579) from Abcam; 
mouse monoclonal anti-LAMP1 (H4A3), rabbit polyclonal anti- 
strumpellin (C-14), and rat monoclonal anti-LAMP1 (1D4B) from Santa 
Cruz Biotechnology, Inc.; rabbit polyclonal anti-GAP DH (2118) from 
Cell Signaling Technology; and Alexa Fluor 488–, 568–, and 647–labeled 
secondary antibodies for immunofluorescence from Molecular Probes.
Constructs
pLXIN-myc-Spastin and pLXIN-myc-IST1 constructs were gener-
ated as previously described (Allison et al., 2013). In brief, M87- or 
M1-spastin was cloned into the pIRESneo2 vector (NheI–BamHI; 
Takara Bio Inc.) followed by insertion of a myc tag (EcoRV–NheI), 
and then myc-spastin was further cloned into the pLXIN vector (SalI–
BamHI; Takara Bio Inc.). Constructs were made resistant to spastin 
siRNA1 and 3 by introducing two mutations into each of the relevant 
sequences by site-directed mutagenesis. Functional mutant versions 
of pLXIN-myc-M87-spastin were then generated by site-directed mu-
tagenesis. Codon-optimized IST1 isoform 1 (UniProt accession no. 
P53990) was synthesized by GenScript. A 5′ myc tag was added by 
axonal swelling. The number of lysosomes in swellings (box 1) and adjacent axonal segments (box 2) was counted and normalized for segment length, 
and the mean ± SEM number of LAMP1-positive vesicles/µm of axonal length are presented in the corresponding histogram (n = 20 swellings). (E) EM 
of lysosomal structures in patient SPG4-1 iPSC-derived cortical neurons. Bars: (EM) 500 nm; (IF main panels) 10 µm; (IF magnified insets) 5 µm. P-values 
generated by two-tailed Student’s t test.
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insertion of IST1 into pIRESneo2-myc (NheI–BamHI). Codon optimi-
zation of the IST1 sequence rendered it resistant to both IST1 siRNA1. 
pBMN-GFP-M1-spastin was generated by cloning EGFP in-frame into 
pIRES-myc-M1-spastin and cloning GFP-M1-spastin from this vec-
tor into an empty pBMN vector. pLXIN-EGFP-SNX1 was generated 
by cloning EGFP-SNX1 from pIRES-EGFP-SNX1 (which encodes an 
N-terminally GFP-tagged murine SNX1 protein; a gift from M. Seaman) 
into the pLXIN vector (SalI–NotI). pLXIN-mCherry-SNX1 was gener-
ated by cloning mCherry into the GFP restriction sites used in the cloning 
of EGFP-SNX1 and pLXIN-EGFP-SNX1. RFP-KDEL (ss-RFP-KDEL) 
was generated as previously described (Altan-Bonnet et al., 2006). In 
brief, the first 30 aa of bovine preprolactin signal sequence were cloned 
into the Nhe1/Pst1 sites of pEGFP-C1 vector (removing the GFP se-
quence; Takara Bio Inc.). Monomeric RFP was mutagenized to insert a 
KDEL ER retention signal 5′ to the stop codon, then this was inserted 
into the prolactin signal sequence-containing vector (Sal1–BamH1). 
pEF321-T expressing SV40 large T antigen was a gift from S. Sugano 
(University of Tokyo, Japan).
Stable cell lines
Stable cell lines were generated by retroviral transduction of HeLaM, 
MRC5, or mouse embryonic fibroblast (MEF) cells, using the spas-
Figure 7. Abnormal lysosomes in strumpellin HSP models. (A) HeLa cells were depleted of strumpellin using four individual siRNAs (strumpellin 1–4), 
fixed, and labeled for LAMP1, then the diameter of the largest lysosome in each cell was measured. The mean ± SEM percentage of cells with a largest 
lysosome >1.8 µm is shown (n = 6 repeats, 100 cells/repeat). The immunoblot verifies strumpellin depletion. (B) EM of endolysosomal structures in wild-
type HeLa cells (mock) or HeLa cells subjected to strumpellin depletion using siRNAs 1–4. With each of the siRNAs, abnormal endolysosomal structures 
encompassing a range of appearances, from those containing very dense networks of membrane to looser coils of membrane, were observed (compare the 
two images shown for strumpellin siRNA 1). (C) HeLa cells were mock-transfected or depleted with strumpellin siRNA, then fixed and visualized for M6PR 
and LAMP1. Colocalization between the two markers was quantified and plotted in the corresponding histogram (n = 3 repeats, 15 cells per condition in 
each repeat). Bars: (EM) 500 nm; (confocal immunofluorescence microscopy [IF] main panels) 10 µm; (IF magnified insets) 5 µm. P-values generated by 
two-tailed Student’s t test.
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tin, IST1 and SNX1 pLXIN and pBMN constructs described earlier. 
A clonal HeLa cell line stably expressing GFP-GOL PH3 and CD8-
ciM6PR (expressing CD8-tagged cytoplasmic tail of the bovine ciMPR 
and GFP-tagged human GOL PH3, at trans-Golgi network-resident 
protein) was a gift from M. Seaman (Seaman, 2004; Breusegem and 
Seaman, 2014). MEFs used to make GFP-SNX1 stable lines were im-
mortalized by transfection with pEF321-T, expressing the SV40 large 
T antigen, and selecting for stable expression by cell survival over time.
Cell culture
HeLaM and MRC5 cells were maintained as previously described 
(Connell et al., 2009). MEFs were prepared from embryonic day 14 
(E14)–E15 mouse embryos and cultured in DMEM supplemented with 
penicillin/streptomycin (Sigma-Aldrich), l-glutamine (Sigma-Aldrich), 
minimal essential amino acids, and β-mercaptoethanol. Spastin mouse 
primary cortical neurons were obtained from E17 mouse embryos or 
day-old pups and cultured on poly-d-lysine–coated glass coverslips in 
neurobasal medium (Invitrogen) with B27 supplement (Invitrogen) and 
l-glutamine (Sigma-Aldrich). After 7 d in culture, neurons were fixed in 
3.7% formaldehyde and processed for immunofluorescence microscopy. 
(Connell et al., 2016). REEP1 KO primary neurons were obtained from 
the cortices of P1 animals and grown on coverslips for 7 d. Cells were 
washed once in PBS and fixed in 4% (vol/vol) formaldehyde.
HeLaM, MRC5, and MEF cells stably expressing spastin, IST1, 
or EGFP-SNX1 constructs were additionally cultured in the presence of 
500 µg/ml Geneticin (Invitrogen). HeLaM cells stably expressing GFP-
GOL PH3 and CD8-ciM6PR were cultured in the presence of both 500 
µg/ml Geneticin (Invitrogen) and 1 µg/ml puromycin (Sigma-Aldrich). 
MRC5 cells stably expressing GFP-M1-spastin and mCherry-SNX1 were 
cultured in the presence of both 500 µg/ml Geneticin (Invitrogen) and 
200 µg/ml Hygromycin B (Thermo Fisher Scientific). Patient fibroblasts 
were cultured in IMDM/Glutamax containing 15% FBS (Invitrogen) 
and 1× penicillin/streptomycin (Invitrogen; Havlicek et al., 2014).
Patients and fibroblast derivation
The patients included were whites with typical characteristics of pure 
spastic paraplegia and mutations in SPA ST. The controls were unrelated 
healthy whites with no history of neurological disease. Human fibro-
blasts were obtained from dermal punch biopsies from the upper arm, 
after Institutional Review Board approval (4120) and written informed 
consent, at the movement disorder clinic at the Department of Molec-
ular Neurology, Universitätsklinikum Erlangen (Erlangen, Germany).
Further details of the patients and cell lines derived from them 
are as follows: fibroblast line SPG4-3, derived from 48-y-old male 
patient with SPA ST mutation c.139A>T, p.Lys47X; fibroblast line 
SPG4-4, derived from 50-y-old female patient with mutation involving 
deletion of exons 1–17 of SPA ST; fibroblast line SPG4-1, derived from 
51-y-old female patient with SPA ST mutation c.1684C>T, p.Arg562X 
(this line was used to derive NPC/neuron lines SPG4-111, SPG4-112, 
and SPG4-123); ctrl-3, derived from a healthy 41-y-old male control 
patient; and ctrl-2, derived from a healthy 45-y-old female patient (this 
line was used to derive NPC/neuron line Ctrl-231).
Animals
Mice were maintained in accordance with UK and European Union 
regulations. Animal work performed in the UK for this study was ap-
proved by the University of Cambridge Ethical Review Committee and 
was performed under project licenses (80/2304 and 70/7888) granted 
by the UK Home Office under the Animals (Scientific Procedures) Act 
1986. The University of Cambridge is a designated establishment for 
Figure 8. Lysosomal abnormalities in REEP1 knockout mice. (A) Primary cortical neurons from REEP1 KO or wild-type littermates were labeled with the 
neuronal marker βIII-tubulin (red) and LAMP1 (green). The diameter of the largest lysosome was measured, and the mean ± SEM percentage of cells with a 
largest lysosome >2 µm is shown (n = 3 repeats, at least 50 cells/repeat). (B) EM of primary cortical neurons from REEP1 KO mice or wild-type littermate 
controls. Middle panels are higher-magnification views of the boxed regions. Bars: (EM) 500 nm; (confocal immunofluorescence microscopy [IF] main 
panels) 10 µm; (IF magnified insets) 5 µm.
JCB • Volume 216 • NumBer 5 • 20171350
breeding and scientific procedures under the Animals (Scientific Pro-
cedures) Act 1986. Animal experiments performed in Germany were 
approved by the local administrative institution (Thüringer Landesamt 
für Verbraucherschutz, Bad Langensalza, Germany).
Cell transfection
In DNA transfections, cells were transfected using Effectene Transfec-
tion Reagent (Qiagen) or Lipofectamine 3000 (Thermo Fisher Scien-
tific) following the manufacturer’s protocol, and typically incubated 
with transfection reagents for 24 h. For siRNA transfection, cells were 
transfected with the relevant siRNAs, using Oligofectamine transfection 
reagent (Invitrogen), according to a protocol modified from Motley et 
al. (2003). In brief, cells were plated into one well of a six-well plate and 
transfected after 24 h. Cells were harvested 48–96 h later. Where cells 
were additionally transfected with a DNA construct during knockdown, 
DNA transfection was performed 24 h before cells were harvested. The 
efficiency of siRNA knockdown was verified by immunoblotting cell 
lysates or by immunofluorescent microscopy of fixed cells, with an an-
tibody against the relevant protein. The following siRNA sequences 
and concentrations were used: spastin (10 nM): siRNA1, 5′-GAA 
CUU CAA CCU UCU AUAA-3′ (Dharmacon D-014070-01); siRNA3, 
5′-UAU AAG UGC UGC AAG UUUA-3′ (Dharmacon D-014070-03); 
IST1 (10 nM): siRNA1, 5′-CCA AGU AUA GCA AGG AAUA-3′ (Dhar-
macon D-020977-01); strumpellin/KIAA0196/SPG8 (predesigned 
oligonucleotides used at 10 nM and ordered from Sigma-Aldrich): 
siRNA1, 5′-CAA CAA ACG CCU UCG UCAA[dT][dT]-3′ (SASI_
Hs02_00346406); siRNA2, 5′-CUA ACA GAC UCU CGG UACA[dT]
[dT]-3′ (SASI_Hs01_00210976); siRNA3, 5′-CAA AUG AUC AGA 
ACC AUUA[dT][dT]-3′ (SASI_Hs02_00346407); and siRNA4, 5′-
CCA CUA UCA GGA CCC UUCA[dT][dT]-3′ (SASI_Hs01_00210979).
Figure 9. Model for spastin mode of action and a proposed HSP cellular pathway. (A) Schematic of the proposed ER–endosome contacts mediated by 
spastin and IST1. The CHMP1B and IST1 complex implicated in fission coats the endosomal tubule. A spastin hexameric complex is in orange, with the 
ATPase domains positioned to cut a microtubule, but for clarity the N-terminal tails of a single M87-spastin and M1-spastin molecule are shown. (B) Sche-
matic diagram of key trafficking pathways influenced by spastin and IST1. Spastin and IST1 drive ER-mediated fission of tubules, decorated by sorting nex-
ins, from the early sorting endosome, thus promoting endosome-to-Golgi traffic of ciM6PR and recycling of TfnR. CiM6PR then captures newly synthesized 
lysosomal enzymes at the Golgi, and the complex is then trafficked back to endosomes, to deliver lysosomal enzymes to the late endosomal/lysosomal 
degradative compartment. For simplicity, only a single ER tubule is shown. Inset, 3D view of the relationship between endosomal tubules, ER tubules, micro-
tubules, and spastin (orange) and IST1 (purple). (C) In cells lacking spastin, fission of endosomal tubules is inhibited (black rectangles), so ciM6PR and 
TfnR are not efficiently sorted away from the endosome and instead are trafficked to the degradative compartment. Reduced availability of ciM6PR at the 
Golgi apparatus results in increased secretion and reduced delivery to the endosomal pathway of lysosomal enzymes. This causes lysosomal morphological 
and functional abnormalities, including increased lysosomal size and the presence of abnormal arrays of dense membrane. (D) Proposed sites of action of 
selected HSP proteins involved in membrane traffic, overlaid onto the trafficking pathways shown in B.
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IPSC derivation and neural differentiation
Fibroblasts from SPG4 patients and controls were reprogrammed using 
retroviral transduction of the transcription factors Klf4, c-Myc, Oct4, 
and Sox2 as previously described (Takahashi et al., 2007; Havlicek et 
al., 2014; Pérez-Brangulí et al., 2014; Mishra et al., 2016). In brief, 
fibroblasts seeded in a six-well plate (Corning) in IMDM/Glutamax 
and 15% FBS (both Invitrogen) were infected three times during 48 h 
with supernatants of Sox2-, Klf4-, and c-Myc–containing retrovirus 
and three times the amount of Oct3/4 by spinfection (800 g for 60 min; 
8 µg/µl Polybrene). 1 d after infection, fibroblasts were detached using 
TrypLE Express and cultured with hESC medium: DMEM/F12/Gluta-
max, 20% Knockout Serum Replacement, 1× NEAA (all Invitrogen), 
55 µM β-mercaptoethanol (Sigma-Aldrich), 20 ng/ml fibroblast growth 
factor 2 (FGF2; PeproTech), and 10 µM SB431542 (Sigma-Aldrich) 
on a feeder layer of irradiated mouse embryonic fibroblasts (EMD Mil-
lipore). Colonies that started to appear at ∼12 d after infection were 
manually isolated and transferred to feeder-free conditions on 24-well 
plates (Corning) coated with 0.5 mg Matrigel (BD) in mTeSR1 medium 
(STE MCE LL Technologies) and expanded clonally. The iPSC lines 
maintained a normal karyotype determined by G-banding analysis. 
Pluripotency was characterized by confirming expression of Nanog 
and Tra-1-60, and the presence of all three embryonic germ layers after 
undirected in vitro differentiation, as described previously (Havlicek et 
al., 2014). To generate NPCs, the iPSCs were transferred to ultra-low- 
attachment plates (Corning) in mTeSR1 (STE MCE LL Technologies) to 
allow the formation of embryoid bodies (EBs). 24 h later, the medium 
was changed to DMEM/F12/Glutamax supplemented with N2 and B27 
(without VitA) and 1× penicillin/streptomycin (all Invitrogen). After 7 
d, the EBs were plated onto plates coated with polyornithine/laminin 
(Invitrogen). Visible rosettes formed within 1 wk and were manually 
picked under a stereomicroscope (Olympus). The neural rosettes were 
dissociated using TrypLE Express (Invitrogen) to form proliferative 
NPC lines. NPCs were maintained at high density, grown on polyor-
nithine/laminin-coated plates in N2/B27 medium supplemented with 
20 ng/ml FGF2 (R&D Systems) and split ∼1:3 every 5–10 d with Try-
pLE Express (Invitrogen). Terminal NPC differentiation was initiated 
in N2/B27 medium supplemented with 20 ng/ml brain-derived neuro-
trophic factor, 20 ng/ml glial cell line–derived neurotrophic factor (both 
Peprotech), 1 mM dibutyryl-cAMP (AppliChem), and 200 nM ascorbic 
acid (Sigma-Aldrich) at a density of ∼40,000 cells/cm2 on glass cov-
erslips (Thermo Fisher Scientific) coated with polyornithine/laminin. 
Neurons were cultured under these conditions for 2–4 wk with a half 
medium change every week (Havlicek et al., 2014; Pérez-Brangulí et 
al., 2014; Mishra et al., 2016).
Immunofluorescence microscopy on fixed cells
Cells were fixed at RT in 3.8% (vol/vol) formaldehyde in PBS and per-
meabilized in PBS containing 0.1% (vol/vol) saponin (Sigma-Aldrich) 
or 0.1% (vol/vol) Triton X-100 (Sigma-Aldrich). Coverslips were la-
beled with primary and secondary antibodies as previously described 
(Connell et al., 2009). In certain cases, soluble cytosolic proteins were 
removed to allow better imaging of membrane-associated protein, by 
prefixation treatment with a saponin-based cytosol extraction buffer, 
as previously described (Edwards et al., 2009). Slides were analyzed 
with an LSM880 confocal microscope (100× NA 1.40 oil immersion 
objective, 37°C), LSM710 confocal microscope (100× NA 1.40 oil 
immersion objective, 37°C), LSM780 confocal microscope (63× NA 
1.40 oil immersion objective, 37°C), or AxioImager Z2 Motorized Up-
right Microscope (63× NA 1.40 oil immersion objective, RT, Axiocam 
506; ZEI SS), all with ZEN analysis software (ZEI SS). Airyscan imaging 
was performed using an LSM880 microscope fitted with an Airyscan 
module, using Plan-Apochromat 63×/1.4-NA Oil differential interfer-
ence contrast (DIC) M27 objective at RT. Images were subsequently 
processed using ImageJ, Adobe Photoshop, Adobe Illustrator, and 
ZEN analysis software. 3D image preparation was performed using 
Imaris (Bitplane). Colocalization of proteins was quantified using 
Volocity (PerkinElmer).
Endosomal tubulation counts on fixed cells
Cells were processed for immunofluorescence microscopy and imaged 
with an AxioImager Motorized Upright Microscope under a 63×/1.4-
NA oil immersion objective as described earlier. Tubulation was quan-
tified using one of two methods: (a) as previously (Allison et al., 2013), 
images of typically 30 cells per condition were randomized and the 
number of tubules per cell longer than 2 µm, up to a maximum of 20 
tubules, was counted blind; and (b) images of typically 30 cells per 
experimental condition were randomized and scored blind for the pres-
ence of tubules longer than 2 µm. The percentage of cells with such 
tubules was then calculated. This technique was less labor-intensive 
than (a) but robustly detected tubulation phenotypes.
ciM6PR trafficking assay
After a 48-h siRNA knockdown of the relevant protein, HeLa cells 
stably expressing GFP-GOL PH3 and CD8-ciM6PR were subjected to 
ciM6PR trafficking assays as described in Seaman (2007). In brief, after 
incubation in medium containing anti-CD8 at 4°C, cells were incubated 
for 24–30 min at 37°C before fixation and processing for immunoflu-
orescence microscopy with an LSM880 confocal microscope as de-
scribed earlier. Colocalization of proteins was quantified using Volocity.
Lysosome quantification
To determine the percentage of cells with large lysosomes, fixed cells 
labeled with LAMP1 were processed for immunofluorescence micros-
copy and imaged with an AxioImager Motorized Upright Microscope 
as described earlier. At least 50 cells were recorded per experimen-
tal condition. Images were randomized, and the largest lysosome per 
cell was measured using ZEN. In axons, the number of lysosomes in 
an axonal swelling (defined as an axonal region labeling with tau and 
>2× the diameter of the adjacent axon) and in the same length of ad-
jacent axon was counted in 20 axons per experiment and expressed 
per micrometer of axon.
To determine the overall distribution of lysosomal size, the ter-
minal degradative compartment was labeled by uptake of fluorescent 
dextran and imaged under assessment of lysosomal pH. Images were 
analyzed with ImageJ to identify individual lysosomal puncta above a 
cutoff threshold of brightness and to measure their surface area. Indi-
vidual cells were delineated from the bright-field DIC signal, and cen-
tral lysosomes were defined as those inside a region of interest drawn 
5 µm from the edge of the cell.
Measurement of lysosomal pH
Lysosomal pH measurement was based on previously described meth-
ods (Bright et al., 2016; Johnson et al., 2016). In brief, cells were 
grown to 80% confluence before incubation for 4 h at 37°C in medium 
containing 1 mg/ml dextran conjugated to Oregon Green (pH sensitive) 
or tetramethylrhodamine (pH insensitive). This was followed by a 20-h 
unlabeled chase before imaging with live-cell microscopy at 37°C 
using an LSM780 microscope (63× NA, 1.40 oil objective). ImageJ 
was used to delineate individual puncta and determine the ratio of 
Oregon Green to tetramethylrhodamine signal for each punctum. The 
pH of each punctum was determined by analysis against a standard 
curve of fluorescence ratio, generated using cells incubated with 10 
µm nigericin and 5 µm monensin in buffers ranging from pH 4.5 to 
6.5, for 10 min before imaging.
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Live-cell microscopy of endosomal tubules and ER
For imaging of GFP-SNX1 alone, cells were grown on 25 mmØ cover-
slips to 60% confluence. Cells were then washed in PBS before imaging 
in Live Cell Imaging Solution (Thermo Fisher Scientific) supplemented 
with 10% (vol/vol) FCS. Cells were imaged using a 63×/1.40-NA iil 
DIC objective (ZEI SS) on a 37°C incubated AxioObserver Z1 inverted 
micro scope fitted with a CSU-X1A Spinning Disk scanhead (Yokogawa) 
and an Andor iXon Ultra 897 EM-CCD (512 × 512) camera driven by 
ZEN Blue software (ZEI SS). Imaging of GFP-SNX1 was performed at 
400-ms exposure per frame, continuously for 3 min. Images were run 
through ZEN Blue’s Single Pixel Filter (threshold 1.5) before export. 
Images were subsequently processed using ImageJ, Adobe Photoshop, 
Adobe Illustrator, and ZEN.
For imaging of ER–endosome dynamics of MRC5 cells, cells 
were grown on 14-mm Microwell No. 1.5 coverglass MatTek dishes 
to 60% confluence. Cells were then washed in phenol red–free DMEM 
supplemented with FCS, l-glutamine, and penicillin/streptomycin be-
fore being imaged in the same medium. Cells were imaged using a 
Nikon 100×/1.49-NA Oil objective on a 37°C incubated Nikon Eclipse 
Ti inverted microscope fitted with a CAI RN MultiCam beamsplitter 
with two Andor iXON Ultra 897 EM-CCD (512 × 512) cameras driven 
by Nikon NIS-Elements software. Imaging of GFP-SNX1 and RFP-
KDEL was performed at 400-ms exposure per frame simultaneously in 
both colors, continuously for 3 min.
In the processing of GFP-SNX1 figures, a mild Gaussian 
blur function was applied to help remove hot pixels. In the process-
ing of ER–endosome figures, images were deconvolved using Huy-
gens Professional software.
Live-cell image quantification
For quantification of GFP-SNX1 endosomal tubule dynamics, tubules 
(defined as linear structures having a length of >1 µm) were observed 
in five cells per condition per experimental repeat. Parameters quan-
tified for each tubule were maximum tubule length, tubule duration 
from formation to fission or collapse, and fate (fission at base, fission 
elsewhere on tubule, or collapse into parent endosome). Fission at the 
tubule base was defined as fission occurring within 1.5 µm of the en-
dosome body. In quantification of GFP-SNX1 endosomal tubules in 
relation to RFP-KDEL labeled ER, GFP-SNX1 tubules >1 µm long 
were identified within regions of the cell with resolvable ER tubules, 
and five cells were observed per condition per experimental repeat. Pa-
rameters quantified were whether endosomal tubule fission occurred in 
relation to an ER tubule and the total duration an endosomal tubule 
contacted an ER tubule between its formation until fission or collapse. 
All quantifications were performed blind by randomization of datasets. 
The total number of tubules analyzed in each set of experiments was 
as follows: MRC5 (spastin KD experiments)/GFP-SNX1 tubule dura-
tion analysis, n = 6, in total 450 tubules analyzed in mock conditions, 
450 in knockdown conditions; MRC5 (spastin KD experiments)/GFP-
SNX1 tubule fate analysis, n = 5 experiments, in total 375 tubules ana-
lyzed in mock conditions, 375 in knockdown conditions; MRC5 (IST1 
KD experiments)/GFP-SNX1 tubule duration and fate analysis, n = 6 
experiments, in total 450 tubules analyzed in mock conditions, 450 in 
knockdown conditions; SpastinN384K MEFs/GFP-SNX1 tubule duration 
and fate analysis, n = 4 experiments, in total 300 tubules analyzed for 
each genotype; MRC5 (spastin KD experiments)/GFP-SNX1 with re-
solvable RFP-KDEL ER tubules analysis, n = 3, in total 211 tubules 
analyzed in mock conditions, 289 in knockdown conditions.
Cathepsin D secretion assay
After a 48-h siRNA knockdown of the relevant protein, HeLa cells 
were processed for cathepsin D secretion as described in Hao et al. 
(2013). In brief, cells were incubated for 16 h in OPTI-MEM, then 
protein was precipitated from culture medium with TCA, suspended in 
SDS-sample buffer, and immunoblotted. Equal loading was determined 
by Coomassie staining of proteins precipitated from the medium and 
immunoblotting of adherent cell lysates. Immunoblot band intensity 
was quantified in ImageJ.
Electron microscopy
Fibroblasts and murine neurons were grown on glass or Thermanox 
(Thermo Fisher Scientific) plastic coverslips and fixed with 2% PFA, 
2.5% glutaraldehyde, and 0.1 M cacodylate buffer (pH 7.2). Human 
iPSC-derived neurons were grown on glass or plastic coverslips 
(Invitrogen) and fixed with 2.5% glutaraldehyde and 0.1  M sodium 
phosphate buffer (pH 7.2). HeLa cells were processed as pellets for 
experiments requiring membrane contact site quantitation. HeLa 
cells were grown on plastic dishes and fixed with 2% PFA, 2.5% 
glutaraldehyde, and 0.1  M cacodylate buffer, pH 7.2, before being 
scraped and spun into a pellet. All samples were postfixed with 
1% osmium tetroxide :1 .5% potassium ferricyanide before being 
incubated with 1% tannic acid to enhance contrast. Cells were 
dehydrated using increasing percentages of ethanol before being 
embedded onto EPON stubs or beam capsules. Resin was cured 
overnight at 65°C, and coverslips were removed using a heat-block 
(plastic) or repetitive freeze-thaw cycles with liquid nitrogen (glass). 
Ultrathin (50- to 70-nm) conventional sections were cut using a 
diamond knife mounted to a Reichart ultracut S ultramicrotome. 
Sections were collected onto copper grids stained using lead 
citrate. Sections were viewed on a FEI Tecnai transmission electron 
microscope at a working voltage of 80 kV.
The total number of organelles analyzed in EM experiments to 
analyze ER–endosome contacts was as follows: HeLa cells (spastin KD), 
n = 3 biological repeats; early endosomes, mock = 23, KD = 21; mul-
tivesicular bodies, mock = 50, KD = 68; SpastinN384K MEFs, early endo-
somes, WT = 36, spastinwt/N384K (HET) = 27, spastinN384K/N384K (KI) = 28; 
multivesicular bodies, WT = 25, Het = 27, KI = 29.
BSA-gold labeling
Gold-conjugated BSA was prepared as previously described (Slot 
and Geuze, 1985). Cells were grown on Thermanox plastic cover-
slips, and 10 nm BSA-gold was incubated continuously with cells 
for 2 h before fixation.
Membrane contact site EM quantitation
Cells were processed as a pellet for conventional EM to ensure random 
orientation of cells. Contact sites were classified as regions of mem-
brane apposition within 20 nm (Eden et al., 2010). Early endosomes 
were defined as vacuolar organelles with one or no intraluminal vesi-
cles. MVBs were defined by the presence of ≥2 intraluminal vesicles 
but no other intraluminal membrane content. ER was distinguished 
from endosomal tubules by its reticular structure and by the presence 
of ribosomes. Occasional endosomal tubules could be seen emanating 
from endosomes, and these were distinguishable from ER, being less 
reticular with a more lucent lumen.
Quantification of endolysosomal ultrastructural morphology
In each experimental condition, randomly chosen sections were an-
alyzed until the morphology of 50 multivesicular bodies (defined as 
containing intraluminal vesicles) or lysosomal organelles was quanti-
fied. The appearances were classified into three groups based on the 
predominant phenotype for each organelle. Vacuolar structures were 
enlarged structures that were electron lucent and contained only sparse 
linear membrane or a few intraluminal vesicles; dense network organ-
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elles contained material that often had a honeycomb appearance or had 
dense coiled or stacked whorls of membrane; and organelles with mem-
brane cords had thick electron-dense belt or cordlike linear structures.
Statistical analysis
Differences from ≥3 independent experiments examining (a) the per-
centage of cells with tubules >2 µm, (b) the number of tubules per 
cell, (c) the percentage of cells with largest lysosome >1.8 or 2 µm, 
(d) Pearson’s coefficient between colocalizing proteins, (e) number of 
lysosomes per μm of axon or per cell, (f) endolysosomal ultrastruc-
tural morphology, or (g) quantification of bands on immunoblot by 
densitometry were compared by paired two-tailed Student’s t tests. All 
live-cell data parameters in MRC5 cells were compared by paired two-
tailed Student’s t tests. Live-cell results in MEFs were compared using 
analysis of variance (ANO VA) for the effect of genotype. Differences 
in ER–endosome contacts detected by EM were analyzed by paired 
two-tailed t tests in HeLa cells and by ANO VA, for the effect of geno-
type, in MEFs. Unpaired two-tailed Student’s t tests were used in ex-
periments with fluorescent dextran to quantify lysosomal size, number, 
and position. Differences between the mean pH of puncta in wild-type 
versus spastin-depleted cells were analyzed using a two-tailed Mann–
Whitney U test. Statistical analysis was performed using GraphPad 
Prism 5.01 for Windows or JMP 10 statistical software (SAS Institute).
Online supplemental material
Fig. S1 contains supporting data to show that spastin promotes endoso-
mal tubule fission at ER contacts. Fig. S2 contains supporting data to 
show that IST1–spastin interaction regulates endosomal tubule fission. 
Fig. S3 contains data supporting a role for spastin in efficient endosome 
to Golgi traffic. Fig. S4 contains supporting data demonstrating that 
spastin regulates lysosomal enzyme traffic and lysosomal morphology. 
Fig. S5 contains supporting data showing siRNA rescue experiments 
that characterize spastin and IST1 sequences required to regulate ly-
sosomal size. Video  1 shows endosome dynamics in wild-type and 
spastin-depleted MRC5 cells stably expressing GFP-SNX1. Video  2 
shows endosome dynamics in MEFs from spastin mouse model, stably 
expressing GFP-SNX1. Video 3 shows that endosomal tubule fission 
occurs at ER tubules in mock-transfected and spastin-depleted MRC5 
cell. Video 4 shows endosomal tubule fission dynamics in a wild-type 
MRC5 cell and a cell depleted of IST1. Video 5 shows that spastin and 
IST1 localize at endosomal tubule constrictions; 3D reconstruction of a 
z-stack of a single SNX1 tubule.
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